Back to Journals » OncoTargets and Therapy » Volume 12

Profile of alectinib for the treatment of ALK-positive non-small cell lung cancer (NSCLC): patient selection and perspectives

Total article views   HTML views PDF downloads Totals
10,380 Dovepress* 8,133+ 1,277 9,410
PubMed Central* 2,247 644 2,891
Totals 10,380 1,921 12,301
*Since 13 June 2019
Total mentioned Facebook Delicious Reddit Twitter Others
7 0 0 1 2 4

View citations on PubMed Central and Google Scholar